Pfizer Inc.
PFE
$26.61
$0.030.11%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.47% | 62.72% | 402.20% | 2,651.13% | 279.00% |
| Total Depreciation and Amortization | -29.48% | -26.37% | -22.92% | 5.44% | 11.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 264.08% | 130.57% | -74.77% | -62.86% | -68.54% |
| Change in Net Operating Assets | 88.10% | -60.50% | 396.32% | -164,800.00% | -41.16% |
| Cash from Operations | -3.59% | 21.27% | 97.00% | 63.08% | 46.48% |
| Capital Expenditure | 30.87% | 31.39% | 33.27% | 20.25% | 25.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.62% | -96.72% | -95.97% | -46.61% | -63.07% |
| Cash from Investing | -299.92% | 88.41% | 89.25% | 112.39% | 108.22% |
| Total Debt Issued | -32.74% | -95.38% | -78.83% | -81.21% | -76.88% |
| Total Debt Repaid | 66.80% | 53.00% | -8.32% | -151.40% | -524.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 22.98% | 23.14% | 23.28% | -2.80% | -2.87% |
| Other Financing Activities | 6.40% | 13.53% | 25.40% | 24.57% | 25.79% |
| Cash from Financing | 58.53% | -94.68% | -161.52% | -172.94% | -165.76% |
| Foreign Exchange rate Adjustments | 100.00% | 10.53% | 65.82% | 31.82% | -65.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -166.67% | -200.00% | -100.00% |
| Net Change in Cash | 93.20% | 101.39% | 122.74% | 148.61% | -173.91% |